Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rhinostics develops and commercializes FDA Class I exempt sample collection devices (e.g., RHINOstic Automated Swab, VERIstic small-volume blood device, HIPPOstic and ELEstic swabs) and associated robotic decapping solutions that enable hands-free, high‑throughput diagnostic workflows for applications such as COVID-19, respiratory panels, STIs, genomics, and other lab tests; these are collection/automation products rather than therapeutic clinical programs[1][2][3][4][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rhinostics.